share_log

Aspira Womens Health Analyst Ratings

Aspira Womens Health Analyst Ratings

Aspira 女性健康分析師評級
Benzinga ·  2023/09/26 11:38
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/26/2023 -23.15% Cantor Fitzgerald → $4 Reiterates Neutral → Neutral
08/22/2023 7.59% Alliance Global Partners → $5.6 Initiates Coverage On → Buy
05/17/2023 -13.54% Cantor Fitzgerald $2 → $4.5 Maintains Neutral
01/20/2023 -61.58% Cantor Fitzgerald $3 → $2 Downgrades Overweight → Neutral
03/29/2021 130.55% Truist Securities → $12 Initiates Coverage On → Buy
01/29/2021 92.12% Cantor Fitzgerald → $10 Initiates Coverage On → Overweight
10/30/2020 William Blair Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
09/26/2023 -23.15% 康託·菲茨傑拉德 →$4 重申 中性→中性
2023年08月22日 7.59% 聯盟全球合作夥伴 →$5.6 開始承保 →購買
2023年05月17日 -13.54% 康託·菲茨傑拉德 $2→$4.5 維護 中性
01/20/2023 -61.58% 康託·菲茨傑拉德 $3→$2 評級下調 超重→中性
03/29/2021 130.55% Truist證券 →$12 開始承保 →購買
2021/01/29 92.12% 康託·菲茨傑拉德 →$10 開始承保 →超重
10/30/2020 - 威廉·布萊爾 開始承保 →跑贏大盤

What is the target price for Aspira Womens Health (AWH)?

阿司匹拉女性健康(AWH)的目標價格是多少?

The latest price target for Aspira Womens Health (NASDAQ: AWH) was reported by Cantor Fitzgerald on September 26, 2023. The analyst firm set a price target for $4.00 expecting AWH to fall to within 12 months (a possible -23.15% downside). 4 analyst firms have reported ratings in the last year.

坎託·菲茨傑拉德於2023年9月26日報道了阿司匹拉婦女健康公司(納斯達克:AWH)的最新目標價。這家分析公司將目標價定為4.00美元,預計AWH將在12個月內降至(可能下跌23.15%)。去年有4家分析公司公佈了評級。

What is the most recent analyst rating for Aspira Womens Health (AWH)?

分析師對Aspira女性健康(AWH)的最新評級是多少?

The latest analyst rating for Aspira Womens Health (NASDAQ: AWH) was provided by Cantor Fitzgerald, and Aspira Womens Health reiterated their neutral rating.

分析師對阿司匹拉女性健康公司(納斯達克代碼:AWH)的最新評級是由坎託·菲茨傑拉德提供的,阿斯皮拉女性健康公司重申了他們的中性評級。

When is the next analyst rating going to be posted or updated for Aspira Womens Health (AWH)?

Aspira女性健康(AWH)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspira Womens Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspira Womens Health was filed on September 26, 2023 so you should expect the next rating to be made available sometime around September 26, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Aspira女性健康公司的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。對Aspira女性健康的上一次評級是在2023年9月26日提交的,所以你應該預計下一次評級將在2024年9月26日左右的某個時候提供。

Is the Analyst Rating Aspira Womens Health (AWH) correct?

分析師對Aspira女性健康(AWH)的評級正確嗎?

While ratings are subjective and will change, the latest Aspira Womens Health (AWH) rating was a reiterated with a price target of $0.00 to $4.00. The current price Aspira Womens Health (AWH) is trading at is $5.21, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Aspira女性健康(AWH)評級被重申,目標價在0.00美元到4.00美元之間。目前阿司匹拉女性健康(AWH)的交易價格為5.21美元,超出了分析師的預測區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論